---
title: Deep Brain Stimulation (DBS) and Motor Evoked Potentials (MEP)
nct_id: NCT05569213
overall_status: UNKNOWN
sponsor: University of Manitoba
study_type: OBSERVATIONAL
primary_condition: MEP Onset Latency
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT05569213.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT05569213"
ct_last_update_post_date: 2022-10-06
last_seen_at: "2026-05-12T06:54:51.585Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Deep Brain Stimulation (DBS) and Motor Evoked Potentials (MEP)

**Official Title:** Combining Deep Brain Stimulation (DBS) and Motor Evoked Potentials (MEP) to Map Activation Loci in the Human Corticospinal Tract

**NCT ID:** [NCT05569213](https://clinicaltrials.gov/study/NCT05569213)

## Key Facts

- **Status:** UNKNOWN
- **Study Type:** OBSERVATIONAL
- **Target Enrollment:** 10
- **Lead Sponsor:** University of Manitoba
- **Conditions:** MEP Onset Latency
- **Start Date:** 2022-10-01
- **Completion Date:** 2023-12-01
- **CT.gov Last Update:** 2022-10-06

## Brief Summary

MEP onset latencies from the hand muscle using two different stimulus methods will be compared from each study participant. Conventional MEP data will be collected prior to skin incision. Following the DBS insertion hand muscle evoked responses will be generated via the DBS electrode. A hand held DBS programmer will be connected to the proximal end of the implanted DBS for delivery of electrical stimuli. Stimulus intensity will be adjusted until a hand muscle evoked potential is registered from the same recording electrodes used for the conventional MEP acquisition. A STN-implanted electrode can produce hand muscle responses due to it's close proximity to the motor fibres of the internal capsule. When the conventional and DBS-induced hand muscle responses have been acquired the study data objectives have been met. Data will be analyzed off-line.

## Detailed Description

Purpose: Hand muscle MEP generated via the DBS electrode will provide an onset latency standard from which we can compare conventional MEP from the same hand muscles. It is critical for validation of conventional MEP to know where in the brain the motor pathway is being stimulated. This will avoid false negative MEP test results.

Objectives: We will measure the onset latencies from hand muscle MEP generated via the DBS electrode as well as using conventional MEP methods. The DBS onset latency data will provide a known anatomical standard to compare with conventional hand MEP.

## Eligibility

- **Minimum age:** 35 Years
- **Maximum age:** 75 Years
- **Sex:** ALL

```
Inclusion Criteria:

* Male or female patients scheduled for DBS surgery under general anesthesia; age 35-75 years; no history of stroke or peripheral nerve disease

Exclusion Criteria:

* peripheral nerve disease (e.g. type I diabetes); demyelinating disease (e.g. multiple sclerosis); previous stroke; allergy to propofol based anesthesia
```

## Arms

- **DBS latency/MEP latency** — Each patient will serve as control and test. Control will be latency of hand MEP generated by DBS stimulation of the corticospinal tract. The test condition will be the latency of hand MEP generated by conventional MEP acquisition.

## Interventions

- **motor evoked potentials** (DIAGNOSTIC_TEST) — see previous descriptions

## Primary Outcomes

- **Combining deep brain stimulation (DBS) and motor evoked potentials (MEP) to map activation loci in the human corticospinal tract** _(time frame: 12 months)_ — onset latency of motor evoked potentials

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT05569213.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT05569213*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*